Cardiovascular protection using beta-blockers - A critical review of the evidence

被引:177
|
作者
Bangalore, Sripal [1 ]
Messerli, Franz H. [1 ]
Kostis, John B. [1 ]
Pepine, Carl J. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Div Cardiol,Hyperten Program, St Lukes Hosp, New York, NY 10019 USA
关键词
D O I
10.1016/j.jacc.2007.04.060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
For more than 3 decades, beta-blockers have been widely used in the treatment of hypertension and are still recommended as first-line agents by national and international guidelines. Recent meta-analyses indicate that, in patients with uncomplicated hypertension, compared with other anti hypertensive agents, first-line therapy with beta-blockers was associated with an increased risk of stroke, especially in the elderly cohort with no benefit for the end points of all-cause mortality, cardiovascular morbidity, and mortality. In this review, we critically analyze the evidence supporting the use of beta-blockers in patients with hypertension and evaluate evidence for its role in other indications. The review of the currently available literature shows that in patients with uncomplicated hypertension, there is a paucity of data or absence of evidence to support use of beta-blockers as monotherapy or as first-line agents. Given the increased risk of stroke, their "pseudo-antihypertensive" efficacy (failure to lower central aortic pressure), lack of effect on regression of target end organ effects like left ventricular hypertrophy and endothelial dysfunction, and numerous adverse effects, the risk benefit ratio for beta-blockers is not acceptable for this indication. However, beta-blockers remain very efficacious agents for the treatment of heart failure, certain types of arrhythmia, hypertropic obstructive cardiomyopathy, and in patients with prior myocardial infarction. (J Am Coll Cardiol 2007; 50:563-72) (c) 2007 by the American College of Cardiology Foundation.
引用
收藏
页码:563 / 572
页数:10
相关论文
共 50 条
  • [41] DISCONTINUING BETA-BLOCKERS
    BRADBERRY, JC
    CLINICAL PHARMACY, 1984, 3 (05): : 457 - &
  • [42] BETA-BLOCKERS FOR GLAUCOMA
    不详
    LANCET, 1979, 1 (8125): : 1064 - 1065
  • [43] BETA-BLOCKERS AND PREGNANCY
    COLLET, D
    EYRAUD, JP
    VINCELOT, A
    AUBARD, Y
    AMAT, P
    BAUDET, JH
    GAZETTE MEDICALE, 1986, 93 (10): : 45 - 47
  • [44] BETA-BLOCKERS AND HYPERTENSION
    LEROUXROBERT, C
    CHARMES, JP
    GAZETTE MEDICALE DE FRANCE, 1979, 86 (03): : 257 - +
  • [45] Better beta-blockers
    Joanna Owens
    Nature Reviews Drug Discovery, 2005, 4 (5) : 371 - 371
  • [46] BETA-BLOCKERS AND THE NEUTROPHIL
    TANNOUS, R
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1987, 109 (02): : 109 - 110
  • [47] BETA-BLOCKERS IN PSYCHIATRY
    DOMINGUEZ, RA
    GOLDSTEIN, BJ
    HOSPITAL AND COMMUNITY PSYCHIATRY, 1984, 35 (06): : 565 - &
  • [48] The vasoldilatory beta-blockers
    Pedersen, Michala E.
    Cockcroft, John R.
    CURRENT HYPERTENSION REPORTS, 2007, 9 (04) : 269 - 277
  • [49] BETA-BLOCKERS IN DIABETICS
    不详
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1986, 128 (50): : 8 - 9
  • [50] FROM BETA-BLOCKERS TO CA2+ BLOCKERS IN HYPERTENSION - A REVIEW
    IAINA, A
    ELIAHOU, HE
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1982, 18 (07): : 735 - 739